CYH COMMUNITY HEALTH SYSTEMS INC
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 1108109 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-7.8%
TTM net income YoY-89.1%
TTM EPS YoY-89.8%
Revenue 3-yr CAGR-2.2%
Net income 3-yr CAGR-46.5%
Margins
Gross margin85.5%
Operating margin10.9%
Net margin0.3%
FCF margin-1.0%
EBITDA margin14.6%
Returns
ROE—
ROA0.3%
ROIC (approx.)7.5%
Asset turnover0.92x
Leverage & solvency
Liabilities / assets107.7%
Debt / equity—
Current ratio1.48x
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.86x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.76B | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.27B |
| Cost of revenue | $407.00M | $401.00M | $441.00M | $446.00M | $460.00M | $469.00M | $489.00M | $507.00M |
| Gross profit | $2.35B | $2.42B | $2.52B | $2.66B | $2.63B | $2.66B | $2.67B | $2.76B |
| Operating income | $146.00M | $389.00M | $281.00M | $450.00M | $243.00M | $512.00M | $284.00M | $278.00M |
| Pretax income | -$53.00M | $180.00M | $64.00M | $221.00M | -$2.00M | $438.00M | $67.00M | $64.00M |
| Income tax | -$3.00M | $76.00M | $89.00M | $61.00M | -$173.00M | $118.00M | $42.00M | $92.00M |
| Net income | -$86.00M | $70.00M | -$58.00M | $110.00M | $130.00M | $282.00M | -$13.00M | -$70.00M |
| EBITDA | $252.00M | $497.00M | $395.00M | $559.00M | $351.00M | $617.00M | $389.00M | $407.00M |
| EPS (basic) | -0.63 | 0.51 | -0.43 | — | 0.97 | 2.11 | -0.10 | — |
| EPS (diluted) | -0.63 | 0.51 | -0.43 | — | 0.96 | 2.09 | -0.10 | — |
| Weighted avg. shares (diluted) | 135.54M | 136.51M | 134.42M | — | 135.19M | 134.88M | 132.88M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $155.00M | $149.00M | $712.00M | $260.00M | $123.00M | $456.00M | $431.00M | $37.00M |
| Receivables | $2.10B | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B |
| Current assets | $3.00B | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B |
| PP&E, net | $4.24B | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B |
| Goodwill | $3.23B | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B |
| Intangibles | — | — | — | $7.00M | — | — | — | $15.00M |
| Total assets | $12.11B | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B |
| Current liabilities | $2.02B | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B |
| Short-term debt | $18.00M | $26.00M | $29.00M | $16.00M | $16.00M | $23.00M | $29.00M | $20.00M |
| Long-term debt | $9.57B | $9.55B | $10.13B | $10.38B | $10.59B | $10.84B | $11.30B | $11.43B |
| Total debt | $9.59B | $9.58B | $10.16B | $10.40B | $10.61B | $10.86B | $11.33B | $11.45B |
| Total liabilities | $13.04B | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B |
| Shareholders' equity | -$1.49B | -$1.39B | -$1.45B | -$1.39B | -$1.50B | -$1.63B | -$1.92B | -$1.91B |
| Net debt | $9.43B | $9.43B | $9.44B | $10.14B | $10.48B | $10.41B | $10.90B | $11.41B |
| Shares outstanding | 141.00M | 141.01M | 140.92M | 138.63M | 140.12M | 140.12M | 140.30M | 138.92M |
| Cash flow statement | ||||||||
| Operating cash flow | $154.00M | $88.00M | -$297.00M | $266.00M | $69.00M | $88.00M | $120.00M | $216.00M |
| Capital expenditure | $87.00M | $76.00M | $76.00M | $94.00M | $65.00M | $91.00M | $85.00M | $109.00M |
| Free cash flow | $67.00M | $12.00M | -$373.00M | $172.00M | $4.00M | -$3.00M | $35.00M | $107.00M |
| Investing cash flow | -$106.00M | -$23.00M | $1.02B | $142.00M | -$81.00M | $342.00M | $444.00M | -$143.00M |
| Financing cash flow | -$42.00M | -$628.00M | -$274.00M | -$271.00M | -$321.00M | -$405.00M | -$170.00M | -$69.00M |
| Depreciation & amortization | $106.00M | $108.00M | $114.00M | $109.00M | $108.00M | $105.00M | $105.00M | $129.00M |
| Stock-based compensation | $3.00M | $2.00M | $3.00M | $4.00M | -$1.00M | $3.00M | $4.00M | $5.00M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.